Brief: Biosynex Signs License Deal For ProciseDx Platform
Oct 21 (Reuters) - BIOSYNEX SA ALBIO.PA :
* ANNOUNCES THE SIGNATURE OF A LICENSE AGREEMENT FOR THE
PROCISEDX
PLATFORM
* STRENGTHENING OF BIOSYNEX'S STAKE IN THE CAPITAL OF
PROCISEDX
* BIOSYNEX'S PERCENTAGE OWNERSHIP IN PROCISEDX INCREASED
FROM
37.17% TO 42.70% FOLLOWING THIS TRANSACTION
Source text for Eikon: ID:nEQ22mqgSa
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals